RxDoctor Payments DataLook up a doctor →

David Clark, MD

Neurology · Overland Park, KSNPI 1629230479

Payments from drug & device makers

$21,762in general payments, 2019–2025

Across 1,234 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$2K
  • Biogen$1K
  • Novartis$1K
  • UCB, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)124$2,079
Sanofi43$1,743
Biogen84$1,431
Novartis92$1,417
UCB, Inc.75$1,383
Teva Pharmaceuticals USA, Inc.119$1,170
Jazz Pharmaceuticals Inc.40$913
AstraZeneca30$844
Genentech USA, Inc.48$842
Lilly USA, LLC45$766
EMD Serono, Inc.40$735
Amgen(2 entities)38$656
Pfizer59$633
Bristol Myers Squibb32$608
Argenx US, Inc.23$480
Catalyst Pharmaceuticals, Inc.25$461
Lundbeck LLC22$379
Banner Life Sciences, LLC17$374
Grifols USA, LLC15$370
Amneal Pharmaceuticals LLC23$358
Acadia Pharmaceuticals Inc17$301
Neurocrine Biosciences, Inc.16$290
Kyowa Kirin, Inc.15$256
Supernus Pharmaceuticals, Inc.12$193
Vanda Pharmaceuticals Inc.7$185
Johnson & Johnson(2 entities)9$167
Sunovion Pharmaceuticals Inc.11$161
Alnylam Pharmaceuticals Inc.9$159
Takeda Pharmaceuticals U.S.A., Inc.7$153
Acorda Therapeutics, Inc8$145
Biohaven Pharmaceuticals, Inc.26$139
CSL Behring7$137
Greenwich Biosciences, Inc.5$124
Upsher-smith Laboratories LLC5$116
Arbor Pharmaceuticals, Inc.7$107
Neurelis, Inc.5$107
Corium, LLC6$102
Ultragenyx Pharmaceutical Inc.5$97
Impel Pharmaceuticals Inc.4$95
Azurity Pharmaceuticals, Inc.5$85
Zyla Life Sciences, Inc.6$82
SK Life Science, Inc.4$81
TG Therapeutics, Inc.3$71
Axsome Therapeutics, Inc.3$68
Livanova USA, Inc.3$62
Xeris Pharmaceuticals, Inc.3$56
Octapharma USA, Inc.3$56
Bio Products Laboratory USA, Inc.2$40
GE HealthCare2$39
Adamas Pharmaceuticals, Inc.2$39
Scilex Pharmaceuticals Inc.2$38
Sumitomo Pharma America, Inc.2$36
Biohaven Pharmaceutical Holding Company Ltd.2$32
Promius Pharma LLC2$29
Mallinckrodt Enterprises LLC2$29
Harmony Biosciences LLC1$27
Aquestive Therapeutics, Inc.2$26
Eisai Inc.2$26
Hospira, Inc.1$26
ANI Pharmaceuticals, Inc.1$26

How this compares

$21,762 in reported general payments places this provider in the 80th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas →

Medicare billing

Part B allowed, 2024
$125,049
Medicare patients
461
Services billed
975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Overland Park

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →